Evotec Se Adr (EVO)

Panoramica Notizia Cronologia dei prezzi Perché EVO Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Evotec Se Adr Stock (EVO) Company Profile

Evotec Se Adr

Healthcare (1111)

Prossima data di guadagno

Ultimi documenti SEC

EVO's Discussions on Twitter

Compare EVO vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EVO Evotec Se Adr	3.51	1.22B	842.96M	-185.63M	-228.52M	-0.5259
TAK Takeda Pharmaceutical Co Adr	18.46	58.03B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	126.65	55.37B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.20	49.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	33.98	39.50B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	473.66	20.50B	3.13B	1.27B	1.12B	26.39

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-03	Iniziato	Berenberg	Buy
2025-04-24	Aggiornamento	Deutsche Bank	Sell → Hold
2024-10-07	Downgrade	Jefferies	Buy → Hold
2024-08-08	Downgrade	Deutsche Bank	Hold → Sell
2024-07-29	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-07-11	Downgrade	Deutsche Bank	Buy → Hold
2024-04-12	Aggiornamento	Deutsche Bank	Hold → Buy
2024-01-18	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-06-23	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-06-16	Downgrade	BofA Securities	Buy → Neutral
2023-06-08	Aggiornamento	Citigroup	Neutral → Buy
2023-04-04	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-12-09	Iniziato	H.C. Wainwright	Buy
2022-11-16	Downgrade	Deutsche Bank	Buy → Hold
2022-08-10	Downgrade	Morgan Stanley	Overweight → Underweight
2022-03-02	Ripresa	Cowen	Outperform
2022-01-07	Ripresa	Citigroup	Neutral

Mostra tutto

Evotec Se Adr Borsa (EVO) Ultime notizie

Evotec Se Adr Azioni (EVO) Dati Finanziari

Evotec Se Adr (EVO)

Evotec Se Adr Stock (EVO) Company Profile

Compare EVO vs TAK, ZTS, HLN, TEVA, UTHR

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Evotec Se Adr Borsa (EVO) Ultime notizie

Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033 - GlobeNewswire Inc.

Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? - Finviz

Financial Review: Evotec (NASDAQ:EVO) & Savara (NASDAQ:SVRA) - Defense World

JustEvotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Chartmill

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Chartmill

Taxes of Evotec SE Sponsored ADR – LSX:A0QZ3J - TradingView — Track All Markets

EvotecHow Low A Company May Go While Still Being Attractive (NASDAQ:EVO) - Seeking Alpha

Evotec Aktie | DE0005664809 | ETR:EVT | News & Aktienkurs | FRA:EVT - LYNX Online Broker

Evotec AG Earnings Call: Resilience Amidst Challenges - MSN

Evotec AG Reports Strategic Shift Amid Mixed Performance - MSN

Annual General Meeting - Evotec

Investor Relations - Evotec

Evotec shares tumble 9% as drug discovery segment weakens - Investing.com

symbol__ Stock Quote Price and Forecast - CNN

ETFs Investing in Evotec SE Sponsored ADR Stocks - TradingView

Evotec (NASDAQ:EVO) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Survey - Defense World

Evotec Ag’s Earnings Call: Mixed Sentiments and Strategic Moves - MSN

Stock Information - Evotec

Evotec SE ADR earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa

Evotec AG Reports Mixed H1 2025 Performance - TipRanks

Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion11.08.25NewsARIVA.DE - rova

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com

EVT Stock Price and Chart — XETR:EVT - TradingView

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com UK

Bayer, BioNxt Solutions, Evotec – falscher Zoll Alarm bei Pharma und Biotech! Welche Aktien lohnen sich? - kapitalerhoehungen.de

Evotec SE Sponsored ADR Trade Ideas — LSX:A0QZ3J - TradingView — Track All Markets

Evotec Stock: Some Recovery Has Come, Much More Is Expected (NASDAQ:EVO) - Seeking Alpha

Evotec SE (NASDAQ: EVO) Announces Departure of Chief Operating Officer Dr. Craig Johnstone - Kalkine Media

Markets Brief: Are Bank Stocks Expensive? - Morningstar

ProShares Nanotechnology ETF Holdings - Quiver Quantitative

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid By Investing.com - Investing.com South Africa

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar Canada

Earnings call: Evotec SE meets 2023 guidance, appoints new CEO - Investing.com

Sandoz Group AG-ADR (SDZNY) Stock Price, News & Analyst Forecast - eToro

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J - Yahoo Finance

Evotec SEADR Shares Near 52-Week LowMarket Mover - Nasdaq

Evotec SE Sponsored ADR Trade Ideas — NASDAQ:EVO - TradingView

Evotec Se Adr Azioni (EVO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EVO